Search results
Results From The WOW.Com Content Network
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022. [ 4][ 5] Novartis manufactures the drugs clozapine (Clozaril), diclofenac (Voltaren; sold to ...
By Sriparna Roy. (Reuters) -The U.S. Food and Drug Administration has approved the use of Novartis' drug to reduce excess protein in the urine of patients with a type of kidney disease, the health ...
D11559. Onasemnogene abeparvovec, sold under the brand name Zolgensma, is a gene therapy used to treat spinal muscular atrophy (SMA), [ 6][ 7] a disease causing muscle function loss in children. It involves a one-time infusion of the medication into a vein. [ 6] It works by providing a new copy of the SMN gene that produces the SMN protein.
Inclisiran, sold under the brand name Leqvio, is a medication used for the treatment of high low-density lipoprotein (LDL) cholesterol and for the treatment of people with atherosclerotic cardiovascular disease (ASCVD), ASCVD risk-equivalents, and heterozygous familial hypercholesterolemia (HeFH). [ 5][ 7][ 6][ 9] It is a small interfering RNA ...
Novartis shareholders are due to vote on the Sandoz spin-off at an extraordinary general meeting on Sept. 15, with the first day of trading scheduled for Oct 4. (Reporting by Ludwig Burger and ...
Pelacarsen. Pelacarsen is an antisense therapy that is designed to reduce Lipoprotein (a) concentrations in people with high levels of the lipoprotein and who are at risk of cardiovascular disease. [ 1][ 2][ 3] It was developed by Ionis Pharmaceuticals and Novartis. [ 4]
A Novartis spokeswoman told Reuters the Swiss company would not disclose details of its collaboration with third parties but that it is "committed to conducting our business in a fully compliant ...
Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. [1] [2] [3] [4] He succeeded Joseph Jimenez who ...